Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016
This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.
Gespeichert in:
| Veröffentlicht in: | JAMA network open 2020-09, Vol.3 (9), p.e2017517-e2017517 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e2017517 |
|---|---|
| container_issue | 9 |
| container_start_page | e2017517 |
| container_title | JAMA network open |
| container_volume | 3 |
| creator | Knisely, Anne T St Clair, Caryn M Hou, June Y Collado, Fady Khoury Hershman, Dawn L Wright, Jason D Melamed, Alexander |
| description | This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer. |
| doi_str_mv | 10.1001/jamanetworkopen.2020.17517 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7519417</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2446671046</sourcerecordid><originalsourceid>FETCH-LOGICAL-a473t-25278fda8873258421e421bada6efcaab4076d1f8cd1e26d75da0fd91726e0f43</originalsourceid><addsrcrecordid>eNpdUU1v1DAUtCpQW5X-BWSVC5cU2_FHwgFptWoBqahI26pH623sbL1N7MVOgvgB_G8ctlSlB-tZb-aN33gQOqPknBJCP2yhB2-HnyE-hJ3154ywjChB1QE6ZkLxoqyIePXsfoROU9oSkom0rKU4REclq5UQsj5Gv2-i9SZh5_H36HqIv3DuwNBbP2DwBn-zxoHHqzFOboIOL_rgN_guZAK-c8M9XpgJfGNNsRpgY_HFLjdt5zL1eoI4zy5nPM5PZATfrvBlDD1mhHA8hFypfINet9Ale_pYT9Dt5cXN8ktxdf3563JxVQBX5VAwwVTVGqgqVTJRcUZtPmswIG3bAKw5UdLQtmoMtUwaJQyQ1tRUMWlJy8sT9GmvuxvXvTVNNhmh07u9cx3A6f8R7-71Jkw6_2_NqcoC7x8FYvgx2jTo3qXGdl3OJIxJM86lVJRwmanvXlC3YYw-29Msc2pGZT1v9HHPamJIKdr2aRlK9By4fhG4ngPXfwPPw2-f23ka_Rdv-QdZKKwO</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2667921694</pqid></control><display><type>article</type><title>Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Knisely, Anne T ; St Clair, Caryn M ; Hou, June Y ; Collado, Fady Khoury ; Hershman, Dawn L ; Wright, Jason D ; Melamed, Alexander</creator><creatorcontrib>Knisely, Anne T ; St Clair, Caryn M ; Hou, June Y ; Collado, Fady Khoury ; Hershman, Dawn L ; Wright, Jason D ; Melamed, Alexander</creatorcontrib><description>This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.</description><identifier>ISSN: 2574-3805</identifier><identifier>EISSN: 2574-3805</identifier><identifier>DOI: 10.1001/jamanetworkopen.2020.17517</identifier><identifier>PMID: 32975569</identifier><language>eng</language><publisher>United States: American Medical Association</publisher><subject>Adenocarcinoma, Mucinous - pathology ; Adenocarcinoma, Mucinous - therapy ; Aged ; Antineoplastic Agents - therapeutic use ; Carcinoma, Endometrioid - pathology ; Carcinoma, Endometrioid - therapy ; Carcinoma, Ovarian Epithelial - pathology ; Carcinoma, Ovarian Epithelial - therapy ; Chemotherapy, Adjuvant - trends ; Cohort Studies ; Cytoreduction Surgical Procedures - trends ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy - trends ; Neoplasm Staging ; Neoplasms, Cystic, Mucinous, and Serous - pathology ; Neoplasms, Cystic, Mucinous, and Serous - therapy ; Oncology ; Online Only ; Ovarian cancer ; Ovarian Neoplasms - pathology ; Ovarian Neoplasms - therapy ; Progression-Free Survival ; Research Letter ; Survival Rate</subject><ispartof>JAMA network open, 2020-09, Vol.3 (9), p.e2017517-e2017517</ispartof><rights>2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright 2020 Knisely AT et al. .</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a473t-25278fda8873258421e421bada6efcaab4076d1f8cd1e26d75da0fd91726e0f43</citedby><cites>FETCH-LOGICAL-a473t-25278fda8873258421e421bada6efcaab4076d1f8cd1e26d75da0fd91726e0f43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,781,785,865,886,27926,27927</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32975569$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Knisely, Anne T</creatorcontrib><creatorcontrib>St Clair, Caryn M</creatorcontrib><creatorcontrib>Hou, June Y</creatorcontrib><creatorcontrib>Collado, Fady Khoury</creatorcontrib><creatorcontrib>Hershman, Dawn L</creatorcontrib><creatorcontrib>Wright, Jason D</creatorcontrib><creatorcontrib>Melamed, Alexander</creatorcontrib><title>Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016</title><title>JAMA network open</title><addtitle>JAMA Netw Open</addtitle><description>This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.</description><subject>Adenocarcinoma, Mucinous - pathology</subject><subject>Adenocarcinoma, Mucinous - therapy</subject><subject>Aged</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Carcinoma, Endometrioid - pathology</subject><subject>Carcinoma, Endometrioid - therapy</subject><subject>Carcinoma, Ovarian Epithelial - pathology</subject><subject>Carcinoma, Ovarian Epithelial - therapy</subject><subject>Chemotherapy, Adjuvant - trends</subject><subject>Cohort Studies</subject><subject>Cytoreduction Surgical Procedures - trends</subject><subject>Female</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Neoadjuvant Therapy - trends</subject><subject>Neoplasm Staging</subject><subject>Neoplasms, Cystic, Mucinous, and Serous - pathology</subject><subject>Neoplasms, Cystic, Mucinous, and Serous - therapy</subject><subject>Oncology</subject><subject>Online Only</subject><subject>Ovarian cancer</subject><subject>Ovarian Neoplasms - pathology</subject><subject>Ovarian Neoplasms - therapy</subject><subject>Progression-Free Survival</subject><subject>Research Letter</subject><subject>Survival Rate</subject><issn>2574-3805</issn><issn>2574-3805</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNpdUU1v1DAUtCpQW5X-BWSVC5cU2_FHwgFptWoBqahI26pH623sbL1N7MVOgvgB_G8ctlSlB-tZb-aN33gQOqPknBJCP2yhB2-HnyE-hJ3154ywjChB1QE6ZkLxoqyIePXsfoROU9oSkom0rKU4REclq5UQsj5Gv2-i9SZh5_H36HqIv3DuwNBbP2DwBn-zxoHHqzFOboIOL_rgN_guZAK-c8M9XpgJfGNNsRpgY_HFLjdt5zL1eoI4zy5nPM5PZATfrvBlDD1mhHA8hFypfINet9Ale_pYT9Dt5cXN8ktxdf3563JxVQBX5VAwwVTVGqgqVTJRcUZtPmswIG3bAKw5UdLQtmoMtUwaJQyQ1tRUMWlJy8sT9GmvuxvXvTVNNhmh07u9cx3A6f8R7-71Jkw6_2_NqcoC7x8FYvgx2jTo3qXGdl3OJIxJM86lVJRwmanvXlC3YYw-29Msc2pGZT1v9HHPamJIKdr2aRlK9By4fhG4ngPXfwPPw2-f23ka_Rdv-QdZKKwO</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Knisely, Anne T</creator><creator>St Clair, Caryn M</creator><creator>Hou, June Y</creator><creator>Collado, Fady Khoury</creator><creator>Hershman, Dawn L</creator><creator>Wright, Jason D</creator><creator>Melamed, Alexander</creator><general>American Medical Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200901</creationdate><title>Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016</title><author>Knisely, Anne T ; St Clair, Caryn M ; Hou, June Y ; Collado, Fady Khoury ; Hershman, Dawn L ; Wright, Jason D ; Melamed, Alexander</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a473t-25278fda8873258421e421bada6efcaab4076d1f8cd1e26d75da0fd91726e0f43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adenocarcinoma, Mucinous - pathology</topic><topic>Adenocarcinoma, Mucinous - therapy</topic><topic>Aged</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Carcinoma, Endometrioid - pathology</topic><topic>Carcinoma, Endometrioid - therapy</topic><topic>Carcinoma, Ovarian Epithelial - pathology</topic><topic>Carcinoma, Ovarian Epithelial - therapy</topic><topic>Chemotherapy, Adjuvant - trends</topic><topic>Cohort Studies</topic><topic>Cytoreduction Surgical Procedures - trends</topic><topic>Female</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Neoadjuvant Therapy - trends</topic><topic>Neoplasm Staging</topic><topic>Neoplasms, Cystic, Mucinous, and Serous - pathology</topic><topic>Neoplasms, Cystic, Mucinous, and Serous - therapy</topic><topic>Oncology</topic><topic>Online Only</topic><topic>Ovarian cancer</topic><topic>Ovarian Neoplasms - pathology</topic><topic>Ovarian Neoplasms - therapy</topic><topic>Progression-Free Survival</topic><topic>Research Letter</topic><topic>Survival Rate</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Knisely, Anne T</creatorcontrib><creatorcontrib>St Clair, Caryn M</creatorcontrib><creatorcontrib>Hou, June Y</creatorcontrib><creatorcontrib>Collado, Fady Khoury</creatorcontrib><creatorcontrib>Hershman, Dawn L</creatorcontrib><creatorcontrib>Wright, Jason D</creatorcontrib><creatorcontrib>Melamed, Alexander</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>JAMA network open</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Knisely, Anne T</au><au>St Clair, Caryn M</au><au>Hou, June Y</au><au>Collado, Fady Khoury</au><au>Hershman, Dawn L</au><au>Wright, Jason D</au><au>Melamed, Alexander</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016</atitle><jtitle>JAMA network open</jtitle><addtitle>JAMA Netw Open</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>3</volume><issue>9</issue><spage>e2017517</spage><epage>e2017517</epage><pages>e2017517-e2017517</pages><issn>2574-3805</issn><eissn>2574-3805</eissn><abstract>This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.</abstract><cop>United States</cop><pub>American Medical Association</pub><pmid>32975569</pmid><doi>10.1001/jamanetworkopen.2020.17517</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2574-3805 |
| ispartof | JAMA network open, 2020-09, Vol.3 (9), p.e2017517-e2017517 |
| issn | 2574-3805 2574-3805 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7519417 |
| source | MEDLINE; DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Adenocarcinoma, Mucinous - pathology Adenocarcinoma, Mucinous - therapy Aged Antineoplastic Agents - therapeutic use Carcinoma, Endometrioid - pathology Carcinoma, Endometrioid - therapy Carcinoma, Ovarian Epithelial - pathology Carcinoma, Ovarian Epithelial - therapy Chemotherapy, Adjuvant - trends Cohort Studies Cytoreduction Surgical Procedures - trends Female Humans Middle Aged Neoadjuvant Therapy - trends Neoplasm Staging Neoplasms, Cystic, Mucinous, and Serous - pathology Neoplasms, Cystic, Mucinous, and Serous - therapy Oncology Online Only Ovarian cancer Ovarian Neoplasms - pathology Ovarian Neoplasms - therapy Progression-Free Survival Research Letter Survival Rate |
| title | Trends in Primary Treatment and Median Survival Among Women With Advanced-Stage Epithelial Ovarian Cancer in the US From 2004 to 2016 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T23%3A58%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Trends%20in%20Primary%20Treatment%20and%20Median%20Survival%20Among%20Women%20With%20Advanced-Stage%20Epithelial%20Ovarian%20Cancer%20in%20the%20US%20From%202004%20to%202016&rft.jtitle=JAMA%20network%20open&rft.au=Knisely,%20Anne%20T&rft.date=2020-09-01&rft.volume=3&rft.issue=9&rft.spage=e2017517&rft.epage=e2017517&rft.pages=e2017517-e2017517&rft.issn=2574-3805&rft.eissn=2574-3805&rft_id=info:doi/10.1001/jamanetworkopen.2020.17517&rft_dat=%3Cproquest_pubme%3E2446671046%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2667921694&rft_id=info:pmid/32975569&rfr_iscdi=true |